Research spans small‑molecule design, organic synthesis and organometallic catalysis to support drug discovery and chemical biology. Uses fragment‑based libraries, structure–activity optimization, and cell‑based assays to translate target engagement into phenotype across oncology, neurodegeneration and cardiometabolic disease.